Blutt Mitchell J Md

Avg. Two Year Performance

76% Avg. Purchase Return
33% Compound
(57%) Avg. Sale Return
(25%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return23%37%72%105%76%
Purchase Success Rate4 of 75 of 76 of 73 of 72 of 7
Average Sale Return(12%)(14%)3%(21%)(57%)
Sale Success Rate5 of 86 of 86 of 82 of 61 of 3
Drugs » Biotechnology

Director:

Holdings: 220.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

134% Purchase Return    53% Compound
159% Sale Return    61% Compound

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--